Teva's (TEVA) Q3 Earnings and Revenues Miss, Stock Down

Mohit Chouhan October 29, 2021
Teva Pharmaceutical Industries' (TEVA) shares decline after the company misses both earnings and sales estimates for third-quarter 2021. Meanwhile, it reaffirms its 2021 guidance.


Post a Comment

0 Comments